Y-mAbs Therapeutics, Inc.
YMAB · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3 | -$5 | -$7 | -$7 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $3 | $4 |
| Change in WC | $4 | -$4 | -$1 | -$4 |
| Other Non-Cash | -$2 | -$1 | $3 | -$4 |
| Operating Cash Flow | $2 | -$7 | -$2 | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $1 | $1 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | $2 | -$7 | -$1 | -$10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60 | $67 | $68 | $78 |
| End Cash | $62 | $60 | $67 | $68 |
| Free Cash Flow | $2 | -$7 | -$2 | -$11 |